SNMMI 2017: Pushing the Limits in Multimodal imaging
With the introduction of its new Series 5 integrated multimodality PET/SPECT/OI/CT platform at the upcoming SNMMI 2017 meeting in Denver, MILabs is pushing the limits of molecular imaging yet again. With hexamodal scalability, <0.15 mm SPECT resolution and PET resolution <0.6 mm – down to the theoretical physical limit for 18F – the Series 5 system features in addition, hybrid nuclear and optical imaging with unmatched morphological 4D CT capabilities. Witness the Unveiling of the new 5 Series on Sunday June 11, 9:45pm, booth 469
Edward J. Hoffman Memorial Lecture
We are pleased to announce that Freek Beekman, founder and CEO of MILabs, is the 2017 recipient of the Society of Nuclear Medicine Computer and Instrumentation Council’s award given in honor of Dr. Hoffman. This award is given annually to an individual in recognition of outstanding contributions to the field of medical imaging science.
The Hoffman Award lecture session is scheduled for Monday June 12, 10:00 am – 11:30 am at the Colorado Convention Center, Room 201
Join us at Breakfast Workshop to learn about the latest innovations in multimodal molecular imaging
“Preclinical PET/CT Imaging of Acute Infectious Diseases: Insights from Dengue Virus”
Dr. Ann-Marie Chacko, PhD – Duke-NUS Medical School, Singapore
“Introduction 5-Series PET/SPECT/OI/CT and User Application Highlights”
Prof. Freek Beekman, PhD – Delft University of Technology, the Netherlands
In a recent publication by Chacko and Watanabe et al. in the Journal of Clinical Investigation, the authors demonstrated the utility of MILabs VECTor system for PET/CT imaging of 18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response in lethally ADE infected S221 DENV2 mouse models. Read more…
New VECTor5OI/CT: Arguably the best ever preclinical imaging system
The new Series-5 PET, SPECT, OI, CT system to be unveiled at the SNMMI 2017 conference is a result of MILabs culture of continuous improvement. Through the aggregation of incremental gains, MILabs has pushed the current performance limits of PET and SPECT yet again beyond the capabilities of any other preclinical nuclear imaging system: image resolutions of <0.6 mm for PET and <0.15 mm for SPECT. Moreover, via hardware and software integration of different imaging technologies, this new system offers single-pass hexamodal imaging capabilities featuring both nuclear and optical molecular imaging complemented by ultra-high resolution, ALARA-dose 3D/4D CT. Read more in the catalog…
MILabs products are used in more than 65 countries and are supported by a global network of distributors and factory trained support engineers.
Please contact MILabs directly for more information about your local MILabs business partner.